SCHEMBL1699528

SCHEMBL1699528

CCc1c(O)cnc2c1[nH]c(=O)n2-c1ccc(OCc2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
PKM P14618 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
DAO P14920 1/20 0.40
LMNA P02545 2/20 0.39
CYP1A2 P05177 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
CYP2C19 P33261 1/20 0.39
PTGS2 P35354 1/20 0.39
SLC6A3 Q01959 1/20 0.39
HIF1A Q16665 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CSNK2A2 P19784 1/20 0.39
CSNK2B P67870 1/20 0.39
CSNK2A1 P68400 1/20 0.39
PRMT5 O14744 6/20 0.39
GABRA1 P14867 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699174 0.88 NPC1 (0.51) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699242 0.83 L3MBTL1 (0.56) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699265 0.83 NPC1 (0.46) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699310 0.80 NPC1 (0.59) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699258 0.78 L3MBTL1 (0.55) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699185 0.77 NPC1 (0.50) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699315 0.75 NPC1 (0.50) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699264 0.74 MAP3K11 (0.40) PKMLMNACSNK2A1HPGDKDM4E
SCHEMBL9981622 0.74 NPC1 (0.58) NPC1RAB9AL3MBTL1PKMSMN1; SMN2
SCHEMBL1699125 0.74 NPC1 (0.56) NPC1RAB9AL3MBTL1PKMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011163355-A1 FUSED HETEROCYCLIC COMPOUNDS AS PHOSPHODIESTERASES (PDES) INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-12-29 WO disclosed